GABI-Balance - A non-interventional observational study on the effectiveness of tiagabine in add-on therapy in partial epilepsy

Neurologia i Neurochirurgia Polska

Volumn 42, Issue 4, 2008, Pages 303-311

  Chmielewska, Barbara ^a   Stelmasiak, Zbigniew ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Add on therapy; Open study; Tiagabine; Treatment effectiveness

Indexed keywords

CARBAMAZEPINE; PHENYTOIN; TIAGABINE; VALPROIC ACID;

ADD ON THERAPY; ADULT; ANAMNESIS; ANXIETY; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL GLOBAL IMPRESSION SCALE; COMPLEX PARTIAL SEIZURE; CONCENTRATION LOSS; CONTROLLED STUDY; DISEASE RESISTANCE; DISEASE SEVERITY; DIZZINESS; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DYSPEPSIA; FATIGUE; FEMALE; FOCAL EPILEPSY; GASTROINTESTINAL DISEASE; GENERALIZED EPILEPSY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; NAUSEA; OBSERVATIONAL STUDY; POLAND; RECOMMENDED DRUG DOSE; SEIZURE; SIDE EFFECT; SIMPLE PARTIAL SEIZURE; SOMNOLENCE;

ADOLESCENT; ADULT; ANTICONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; EPILEPSIES, PARTIAL; FEMALE; GABA AGONISTS; HUMANS; MALE; MIDDLE AGED; NEUROPROTECTIVE AGENTS; NIPECOTIC ACIDS; POLAND; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 56649100454     PISSN: 00283843     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Kwan P., Sander J.W. The natural history of epilepsy: an epidemiological view. J Neurol Neurosurg Psychiatry 2004; 75: 1376-1381.
2. Marson A.G., Kadir Z.A., Hutton J.L., et al. The new antiepileptic drugs: a systematic review of their efficacy and tolerability. Epilepsia 1997; 38: 859-880.
3. Leach J.P., Brodie M.J. Drug profile tiagabine. Lancet 1998; 351: 203-207.
4. Schmidt D., Gram L., Brodie M., et al. Tiagabine in the treatment of epilepsy - a clinical review with a guide for the prescribing physician. Epilepsy Res 2001; 41: 245-251.
5. McKee P. Treating refractory epilepsy with tiagabine: clinical experience. Seizure 2004; 13: 478-480.
6. Chadwick D.W., Marson T., Kadir Z. Clinical administration of new antiepileptic drugs: an overview of safety and efficacy. Epilepsia 1996; 37 (Suppl. 6): S17-22.
7. Cramer J.A., Fisher R., Ben-Menachem E., et al. New antiepileptic drugs: comparison of key clinical trials. Epilepsia 1999; 40: 590-600.
8. Salas-Puig J. Gabitril Epilepsy Observational Study (GEOS): a multinational observational study of tiagabine in partial epilepsy. Epilepsia 2003; 44 (Suppl 8): 40-41.
9. Niedzielska K. GEOS (Gabitril Epilepsy Observational Study) - polskie wyniki miedzynarodowego badania tiagabiny u chorych na padaczke z napadami cześciowymi. Neurol Neurochir Pol 2005; 39: 459-465.
10. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1981; 22: 489-501.
11. Ben-Menacheni E. International experience with tiagabine add-on therapy. Epilepsia 1995; 36 (Suppl 6): S14-S21.
12. Richens A., Chadwick D.W., Duncan J.S., et al. Adjunctive treatment of partial seizures with tiagabine: a placebo-controlled trial. Epilepsy Res 1995; 21: 37-42.
13. Leppik I.E. Tiagabine: the safety landscape. Epilepsia 1995; 36 (Suppl 6): S10-S13.
14. Leppik I.E., Gram L., Deaton R., et al. Safety of tiagabine: summary of 53 trials. Epilepsy Res 1999; 33: 235-246.
15. Bauer J., Bergmann A., Reuber M., et al. Tolerability of tiagabine: a prospective open-label study. Epileptic Disord 2002; 4: 257-260.
16. Deckers C.L., Czuczwar S.J., Hekster Y.A., et al. Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed. Epilepsia 2000; 41: 1364-1374.